FOUNDER, CHAIRMAN AND CEO
20 years of experience in the global healthcare industry
Chairman, CEO Ruthigen, Inc.
IPO experience, including raising $170M in capital
FDA and CE approvals of multiple drugs and devices
CO-FOUNDER, VP OF BUSINESS DEVELOPMENT AND SALES
Vice President, Sales and Business Development
Investment Banker completed over $400M in transactions
Director of National Investment Bankers Association
Bani tchekanova, PH.D.
VICE PRESIDENT REGULATORY AFFAIRS
Extensive experience in the pharmaceutical industry, research and development for marketed and in development products, global Regulatory affairs and clinical research.
Has held positions in industry as Director of Clinical Operations at Artemis, Director of Regulatory Affairs at Merck Serono, Head of International Labeling Operation at Boehringer Ingelheim and Therapeutic Lead in oncology at Abbott.
Extensive scientific, drug development and regulatory experience.
Earned a Ph.D. in healthcare administration, MS in clinical laboratory sciences, and two bachelor degrees in biology and chemistry.
DIRECTOR OF FINANCE
Served as Chief Financial Officer of Ruthigen, Inc.
Buy-side and Sell-side equity research analyst covering medical devices and diagnostics sectors with Symmetry Capital, Needham & Co., and ThinkEquity
Held research positions at Guidant (now Abbott Laboratories) and Synteni (acquired by Incyte Corporation)